MedPath

Pharmaceutical Standardization Of Yashada Bhasma and their clinical efficacy in Type-II Diabetes Mellitus.

Phase 2
Completed
Conditions
Health Condition 1: null- Patients suffering from the signs and symptoms of type 2 DM
Registration Number
CTRI/2016/02/006684
Lead Sponsor
IPGT AND RA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
92
Inclusion Criteria

Both the sexes having Age between 30 years to 60 years

Patients having classical symptomatology of Madhumeha

(Prabhutamutrata, Avilamutrata etc)

Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight

loss)

Patients having Blood sugar

Fasting Blood Sugar ? 126 mg/dl

Post Prandial Blood Sugar ? 200 mg/dl

Exclusion Criteria

1.Age below 30 and above 65 years.

2.Malignant and accelerated Hypertension.

3.Patients having chronic complications of Diabetes Mellitus

a.Microvascular: Retinopathy, Neuropathy, & Nephropathy.

b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.

c.Other chronic debilitating diseases like STD etc.

4.Pregnant women

5.Lactating mothers

6.Secondary Diabetes mellitus

7.Patients of any other severe illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath